• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[克罗恩病治疗中骨脱钙的患病率]

[Prevalence of bone decalcification in the treatment of Crohn's disease].

作者信息

Kociánová J, Axmann K

机构信息

II. interní oddĕlení FN Bulovka, Praha.

出版信息

Vnitr Lek. 1992 Oct;38(10):945-51.

PMID:1481371
Abstract

In clinically active Crohn's disease the bone mineralization is impaired due to calcium malabsorption by the inflamed intestinal wall which is potentiated by diarrhoea and the thus accelerated transit time. To this we must add the shortening of the gut after operations, the inadequate dietary calcium supply or possibly calcium elimination in case of concurrent lactose intolerance. Corticoid treatment leads also to deterioration of bone mineralization. This is the reason why the authors assessed in 98 patients with Crohn's disease the bone mineralization, using the method of clavicular bone index (NIBA). Then treatment was started: a high protein diet, calcium forte, Ossin (sodium fluoride), vitamin D forte, anabolics and regular physical exercise. Check-up examinations after one year revealed that the index was restored in the majority of patients (60.84%) to normal. The above treatment is thus effective. It must be, however, regular and of a long-term character, in some patients it must extend over many years. We had, however, also patients who although subjected to an extensive resection of the gut and treated for prolonged periods with corticoids, had permanently an index between 100 and 120% without treatment.

摘要

在临床活动期的克罗恩病中,由于炎症肠壁对钙的吸收不良,加上腹泻以及由此加快的转运时间,导致骨矿化受损。此外,手术造成的肠管缩短、饮食中钙供应不足,或者在并发乳糖不耐受时可能出现的钙排泄增加,也会加重这种情况。皮质类固醇治疗同样会导致骨矿化恶化。这就是作者采用锁骨骨指数(NIBA)法对98例克罗恩病患者的骨矿化情况进行评估的原因。随后开始治疗:采用高蛋白饮食、钙补充剂、奥新(氟化钠)、高剂量维生素D、合成代谢药物以及定期体育锻炼。一年后的复查显示,大多数患者(60.84%)的指数恢复正常。因此,上述治疗方法是有效的。然而,治疗必须规律且长期进行,在某些患者中,治疗必须持续多年。不过,我们也有一些患者,尽管接受了广泛的肠切除术并长期使用皮质类固醇治疗,但未经治疗时其指数始终在100%至120%之间。

相似文献

1
[Prevalence of bone decalcification in the treatment of Crohn's disease].[克罗恩病治疗中骨脱钙的患病率]
Vnitr Lek. 1992 Oct;38(10):945-51.
2
Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation.长期口服补充维生素D预防克罗恩病患者的骨矿物质流失
Eur J Gastroenterol Hepatol. 1995 Jul;7(7):609-14.
3
[Disorders of bone mineralization and their treatment in Crohn's disease].[克罗恩病中的骨矿化紊乱及其治疗]
Vnitr Lek. 1998 Mar;44(3):162-5.
4
Hyperhomocysteinaemia is associated with osteoporosis in patients with Crohn's disease.高同型半胱氨酸血症与克罗恩病患者的骨质疏松症相关。
Aliment Pharmacol Ther. 2007 Apr 1;25(7):797-804. doi: 10.1111/j.1365-2036.2007.03260.x.
5
[Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].[慢性炎症性肠病中的病理性骨密度——患病率及危险因素]
Z Gastroenterol. 1999 Jan;37(1):5-12.
6
Osteopenia in Puerto Ricans with Crohn's disease.患有克罗恩病的波多黎各人的骨质减少
P R Health Sci J. 2000 Dec;19(4):329-33.
7
[Bone demineralization in Crohn's disease, its diagnosis, therapy and prevention].[克罗恩病中的骨质脱矿,其诊断、治疗与预防]
Cas Lek Cesk. 1999 Aug 30;138(17):522-4.
8
Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.肿瘤坏死因子-α单倍型与克罗恩病患者的骨矿物质密度密切相关。
J Gastroenterol Hepatol. 2007 Jun;22(6):913-9. doi: 10.1111/j.1440-1746.2006.04679.x.
9
Vitamin B12 absorption after ileorectal anastomosis for Crohn's disease: effect of ileal resection and time span after surgery.克罗恩病回直肠吻合术后的维生素B12吸收:回肠切除及术后时间跨度的影响
Eur J Gastroenterol Hepatol. 1995 May;7(5):397-400.
10
Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: a case-control cross-sectional study of 113 patients.性别、年龄和体重是克罗恩病骨密度的主要预测因素:一项针对113例患者的病例对照横断面研究。
Am J Gastroenterol. 1999 Mar;94(3):824-8. doi: 10.1111/j.1572-0241.1999.00866.x.